AstraZeneca has recorded its highest quarterly revenue to date, achieving a ten per cent increase and surpassing analyst expectations. The FTSE 100 pharmaceutical group announced total third quarter revenue had
All posts tagged in US investment
4Articles
GSK, one of Britain’s foremost pharmaceutical giants, has announced an ambitious plan to invest $30 billion in the United States over the coming five years. This investment will bolster research
AstraZenecas chief executive has described the pharmaceutical giant as a very American company following rising speculation about a potential shift of its main stock market listing from London to New
Donald Trump has announced plans to expedite regulatory approvals for investors committing $1 billion or more to the United States, signalling a significant shift towards deregulation rather than the tax
